220 related articles for article (PubMed ID: 24868582)
21. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
[TBL] [Abstract][Full Text] [Related]
22. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
23. Histopathologic observations after intra-arterial chemotherapy for retinoblastoma.
Eagle RC; Shields CL; Bianciotto C; Jabbour P; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1416-21. PubMed ID: 21746972
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
25. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
Padrón-Pérez N; Català-Mora J
J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
[No Abstract] [Full Text] [Related]
26. Intra-arterial chemotherapy for retinoblastoma: Two-year results from tertiary eye-care center in India.
Rishi P; Sharma T; Sharma M; Maitray A; Dhami A; Aggarwal V; Munusamy S; Ravikumar R; Ramamurthy S
Indian J Ophthalmol; 2017 Apr; 65(4):311-315. PubMed ID: 28513496
[TBL] [Abstract][Full Text] [Related]
27. Diffuse chorioretinal atrophy after a single standard low- dose intravitreal melphalan injection in a child with retinoblastoma: a case report.
Chao A; Kao LY; Liu L; Wang NK
BMC Ophthalmol; 2016 Mar; 16():27. PubMed ID: 26975871
[TBL] [Abstract][Full Text] [Related]
28. Globe Salvage With Intra-Arterial Topotecan-Melphalan Chemotherapy in Children With a Single Eye.
Leal-Leal CA; Asencio-López L; Higuera-Calleja J; Bernal-Moreno M; Bosch-Canto V; Chávez-Pacheco J; Isaac-Otero G; Beck-Popovic M
Rev Invest Clin; 2016; 68(3):137-42. PubMed ID: 27409000
[TBL] [Abstract][Full Text] [Related]
29. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma.
Brodie SE; Pierre Gobin Y; Dunkel IJ; Kim JW; Abramson DH
Doc Ophthalmol; 2009 Aug; 119(1):13-22. PubMed ID: 19169884
[TBL] [Abstract][Full Text] [Related]
30. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
[TBL] [Abstract][Full Text] [Related]
31. Real-time ophthalmoscopic findings of intraophthalmic artery chemotherapy in retinoblastoma.
Fallaha N; Dubois J; Carret AS; Callejo SA; Hamel P; Superstein R
Arch Ophthalmol; 2012 Aug; 130(8):1075-7. PubMed ID: 22893086
[No Abstract] [Full Text] [Related]
32. Histopathology of retinoblastoma eyes enucleated after intra-arterial chemotherapy.
Biewald EM; Bornfeld N; Metz KA; Schlüter S; Kiefer T; Radbruch A; Göricke S; Sirin S; Ketteler P; Bechrakis NE
Br J Ophthalmol; 2020 Aug; 104(8):1171-1175. PubMed ID: 31676593
[TBL] [Abstract][Full Text] [Related]
33. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
34. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
36. Selective Ophthalmic Artery Infusion Chemotherapy for Advanced Intraocular Retinoblastoma: CCHMC Early Experience.
Michaels ST; Abruzzo TA; Augsburger JJ; Corrêa ZM; Lane A; Geller JI
J Pediatr Hematol Oncol; 2016 Jan; 38(1):65-9. PubMed ID: 26583615
[TBL] [Abstract][Full Text] [Related]
37. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
Hutchinson A; Kaliki S; Shields CL
J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
[TBL] [Abstract][Full Text] [Related]
38. INTRAVITREAL MELPHALAN AS SALVAGE THERAPY FOR REFRACTORY RETINAL AND SUBRETINAL RETINOBLASTOMA.
Francis JH; Marr BP; Brodie SE; Gobin P; Dunkel IJ; Abramson DH
Retin Cases Brief Rep; 2016; 10(4):357-60. PubMed ID: 26630243
[TBL] [Abstract][Full Text] [Related]
39. Intra-Arterial Chemotherapy for Retinoblastoma: 8-Year Experience from a Tertiary Referral Institute in Thailand.
Rojanaporn D; Chanthanaphak E; Boonyaopas R; Sujirakul T; Hongeng S; Ayudhaya SSN
Asia Pac J Ophthalmol (Phila); 2019; 8(3):211-217. PubMed ID: 30714357
[TBL] [Abstract][Full Text] [Related]
40. Intra-arterial Chemotherapy as Primary Treatment for Cavitary Retinoblastoma: Excellent Response in Eight Tumors.
Zheng Y; Froehler MT; Friedman DL; Daniels AB
Ophthalmol Retina; 2021 May; 5(5):479-485. PubMed ID: 32853834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
